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Previous work indicated that lysine-specific deme-
thylase 1 (Lsd1) can positively regulate the oxidative
and thermogenic capacities of white and beige adi-
pocytes. Here we investigate the role of Lsd1 in
brown adipose tissue (BAT) and find that BAT-selec-
tive Lsd1 ablation induces a shift from oxidative to
glycolytic metabolism. This shift is associated with
downregulation of BAT-specific and upregulation of
white adipose tissue (WAT)-selective gene expres-
sion. This results in the accumulation of di- and tria-
cylglycerides and culminates in a profoundwhitening
of BAT in aged Lsd1-deficient mice. Further studies
show that Lsd1 maintains BAT properties via a dual
role. It activates BAT-selective gene expression in
concert with the transcription factor Nrf1 and re-
presses WAT-selective genes through recruitment
of the CoREST complex. In conclusion, our data un-
cover Lsd1 as a key regulator of gene expression and
metabolic function in BAT.INTRODUCTION
Adipose tissue is an important metabolic regulator of energy bal-
ance (Langin, 2010). In mammals, three types of adipose tissues
exist. White adipose tissue (WAT) is essentially composed of
white adipocytes containing one single large lipid vesicle. WAT
is mainly located in the abdominal and subcutaneous areas of
the body and is highly adapted to store excess energy in the
form of triacylglycerides. Conversely, beige and brown adipo-
cytes are highly energy-expending (Lee et al., 2014a). They are
able to dissipate energy in the form of heat via the action of un-
coupling protein-1 (Ucp1) (Tiraby and Langin, 2003). Brown1008 Cell Reports 17, 1008–1021, October 18, 2016 ª 2016 The Auth
This is an open access article under the CC BY-NC-ND license (http://adipocytes reside in discrete brown adipose tissue (BAT)
depots, such as the interscapular area in rodents, whereas beige
adipocytes are intermingled with white adipocytes in WAT. Both
brown and beige adipocytes have amultilocular morphology and
large numbers of mitochondria and express a common set of
brown/beige fat-selective genes, including Ucp1 (Lee et al.,
2014b). In rodents, heat generated by brown or beige adipocytes
via Ucp1 is essential to survive the cold season (Cohen and Spie-
gelman, 2015). In both cell types, the cold response is mainly
regulated by the sympathetic nervous system, in particular by
the b3-adrenergic signaling pathway (Cannon and Nedergaard,
2004). In addition to its role in thermogenesis and fatty acid
oxidation, it has been reported that BAT activated by the b3-
adrenergic signaling pathway can improve glucose homeostasis
(Peirce and Vidal-Puig, 2013).
Because recent studies have shown that brown/beige adipo-
cytes exist in quantifiable amounts in humans (Betz and Ener-
ba¨ck, 2015), these fat types have been rediscovered as potential
therapeutic targets for weight loss. Therefore, understanding
brown/beige adipocyte function and finding new ways to modu-
late their activity has become a major scientific point of interest
(Betz and Enerba¨ck, 2015). Among other factors (Harms et al.,
2014; Kleiner et al., 2012; Puigserver et al., 1998; Vernochet
et al., 2012), the epigenetic regulator lysine-specific demethy-
lase 1 (Lsd1) (Cai et al., 2014; Metzger et al., 2005, 2016), a
flavin adenine dinucleotide (FAD)-dependent amine oxidase,
has been shown to regulate the differentiation and function of
white and beige adipocytes (Duteil et al., 2014; Musri et al.,
2010). InWAT, Lsd1 is induced by cold and involved inmediating
the effects of b3-adrenergic signaling. Notably, we recently
demonstrated that increased expression of Lsd1 in mouse
WAT promotes the development of thermogenically active beige
adipocytes and suppresses metabolic disorders such as obesity
and type 2 diabetes (Duteil et al., 2014). Moreover, in mature
white adipocytes, elevation of Lsd1 levels is sufficient to acti-
vate mitochondria biogenesis, oxidative phosphorylation, andor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Lsd1 Represses the Expression of
WAT-Selective Genes in BAT
(A–E) Macroscopic view (A), mass (B and C), H&E
staining (D), and ultrastructure analysis (E) of
representative sections of BAT of control (Ctrl),
Lsd1cKO, and Lsd1cKI mice.
(B and C) Mean + SEM, **p < 0.01, ***p < 0.001.
(B) Ctrl, n = 9; Lsd1cKO, n = 7.
(C) Ctrl, n = 7; Lsd1cKI, n = 6.
(F) Heatmap comparing mRNA levels of BAT- and
WAT-selective genes in BAT and WAT of control
mice (BAT/WAT) and in BAT of Lsd1cKO and control
mice (cKO/Ctrl) at 10 weeks of age (Ctrl, n = 4;
Lsd1cKO, n = 4).
(G and H) Relative mRNA levels of WAT-selective
(G) and BAT-selective (H) genes in BAT of control,
Lsd1cKO, and Lsd1cKI mice (mean + SEM, *p < 0.05,
**p < 0.01, ***p < 0.001; Ctrl [black bars], n = 9;
Lsd1cKO [orange bars], n = 7; Ctrl [white bars], n = 7;
Lsd1cKI [red bars], n = 6).
Scale bars, 5 mm (A), 100 mm (D), 10 mm (E). See
also Figure S1 and Table S1.thermogenesis (Duteil et al., 2014). In contrast, the role of Lsd1 in
BAT has not been investigated in detail. Brown fat cells exhibit a
gene expression profile distinct from either beige or white adipo-
cytes (Wu et al., 2012). Because Lsd1 is a key regulator of meta-
bolism in mature white or beige adipocytes, we asked whether
Lsd1 might also play a role in controlling brown adipocyte
function.
In this study, we show that selective ablation of Lsd1 or inac-
tivation of its catalytic activity in brown adipocytes triggers a
profound whitening of BAT. Lsd1 loss and genetic or chemical
inhibition elicits a dramatic rise in expression of WAT-selective
genes while impairing the expression of BAT-selective genes.all
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daCell RepOur data demonstrate that Lsd1 acts via a
dual mechanism by positively regulating
the expression of BAT-selective genes
in cooperation with Nrf1 and actively re-
pressing the expression of WAT-selective
genes in concert with the CoREST com-
plex. The whitening of BAT observed
upon depletion or inhibition of Lsd1 is
accompanied by a shift from oxidative to
glycolytic metabolism associated with an
accumulation of di- and triacylglycerides.
This collapse of BAT function accelerates
body weight gain but improves glucose
tolerance. Taken together, our results
demonstrate that Lsd1 is essential to
maintain the metabolic function of brown
adipose tissue.
RESULTS
Lsd1 Represses the White Fat
Program in Brown Adipose Tissue
To investigate the role of Lsd1 in BAT, we
crossed mice harboring conditional Lsd1eles (Zhu et al., 2014) with the Ucp1-Cre deleter strain (Turpin
al., 2014), which resulted in Cre-mediated loss of Lsd1 selec-
ely in brown and beige adipocytes (Lsd1Ucp1-Cre, hereafter
med Lsd1cKO) (Figures S1A and S1B). At 10 weeks of age,
d1cKO mice exhibited a profound morphological whitening of
eir BAT (Figure 1A). This whitening was accompanied by an
0% increase in tissue mass (Figure 1B), a switch from multi-
ular to unilocular morphology, and increased lipid content
igures 1D and 1E). In Lsd1cKO mice, the morphology of mito-
ondria was severely altered with substantially augmented
e and less densely packed cristae (Figure S1C). In accor-
nce, the DNA content of mitochondria was decreased byorts 17, 1008–1021, October 18, 2016 1009
around 60% in Lsd1cKO mice (Figure S1D), indicating degrada-
tion and dysfunction of this organelle. These observations sug-
gested that loss of Lsd1 in brown adipocytes shifted BAT toward
a white fat-like phenotype.
Accordingly, we expected to see changes in the tran-
scriptional program of brown adipocytes of Lsd1cKO mice
that resemble the gene expression profile observed in white
adipocytes. We therefore determined the transcriptome of
Lsd1-deleted BAT and compared it with the transcriptome of
WAT of control mice, which was described previously (Fitzgib-
bons et al., 2011; Figure 1F; Table S1). The vast majority of
WAT-selective genes (95%) was upregulated in BAT of Lsd1cKO
mice, whereas 67% of BAT-selective genes showed reduced
expression (Figure 1F; Table S1). qRT-PCR analysis confirmed
that the white fat transcriptome was enhanced to the detriment
of the brown fat program, as illustrated by significantly increased
expression of representative WAT-selective genes such as
Bmp4, Egfr, Pdk3, Fads1, Apoe, Klhl13, Rtn1, Bmp1, and Wls
(Figure 1G) and decreased expression of representative BAT-se-
lective genes (Ucp1, Slc27a2, Cox8b, Acadl, Cox6a1, Acadm,
Oplah, Prdm16, and Cox17) (Figure 1H) in Lsd1cKO mice. In line
with these RNA expression data, western blot analyses showed
that BAT of Lsd1cKO mice expressed higher levels of Apoe and
reduced levels of Ucp1 protein (Figure S1E). These data suggest
that, in BAT, Lsd1 is required to repress the expression of white
fat-selective genes while supporting the brown fat-selective
gene expression program.
Lsd1 Demethylase Activity Is Required to Maintain the
Gene Expression Program of BAT in Mice
To determine whether Lsd1 demethylase activity is required to
maintain the brown fat program, we engineered mice homozy-
gous for a conditional, enzymatically inactive mutant Lsd1
knockin allele (Lsd1KI/KI/Ucp1-Cre, hereafter named Lsd1cKI) (Fig-
ures S1F–S1I). In BAT of these mice, the endogenous Lsd1
gene is replaced by an enzymatically inactive Lsd1 mutant allele
following Ucp1-Cre-mediated recombination. As observed in
Lsd1-depleted mice, we found that BAT of Lsd1cKI mice was
increased in size and contained a large proportion of unilocular
adipocytes (Figures 1A and 1C–1E). Although Lsd1 mRNA levels
remained unchanged (Figure S1H), the expression levels of
WAT-selective genes were increased, whereas the levels of
BAT-selective genes were decreased (Figures 1G and 1H; Fig-
ure S1I). In conclusion, alterations in BAT morphology and tran-
scription pattern in Lsd1cKI mice resemble those of Lsd1cKO
mice, demonstrating that Lsd1 demethylase activity contributes
to the phenotype observed in genetically modified mice.
Because the expression of Ucp1 is initiated in utero between
embryonic day (E) 18.5 and E19.5, Lsd1 ablation by Ucp1-Cre-
mediated recombination is expected to occur around birth (Giralt
et al., 1990). To investigate the role of Lsd1 in adult BAT, 10-
week-old wild-type mice were treated for 5 days with the
Lsd1-specific nanomolar affinity inhibitor QC6688 (Lsd1(i)) or
vehicle. BAT of mice treated with Lsd1(i) showed a profoundly
pale color and increased size compared with that of vehicle-
treated mice (Figure 2A; Figure S2A). H&E staining of BAT sec-
tions revealed that Lsd1(i)-treated adipocytes had larger lipid
droplets compared with those of vehicle-treated mice (Fig-1010 Cell Reports 17, 1008–1021, October 18, 2016ure 2B). The expression levels of representative WAT-selective
genes were increased at both mRNA and protein levels (Figures
2C and 2E), whereas expression of representative BAT-selective
genes was decreased in QC6688-treated mice (Figures 2D and
2E). These data corroborate our findings in Lsd1cKI mice and
suggest that catalytically active Lsd1 is required to maintain
the metabolic properties of BAT.
To investigate the cell autonomy of Lsd1(i) in BAT, we treated
differentiated primary brown adipocytes (hereafter named brown
adipocytes) isolated from the stromal vascular fraction with
Lsd1(i) or vehicle for 3 days. As shown by oil red O staining,
Lsd1(i)-treated brown adipocytes accumulated more fat than
vehicle-treated cells (Figure 2F) and shifted their transcription
pattern to a white adipocyte-like program (Figures S2B–S2D).
Together, these data demonstrate that the gene expression pro-
gram of brown adipocytes is controlled by the catalytic activity of
Lsd1 in a cell-autonomous manner.
Lsd1 Has a Dual Role in Controlling Expression of BAT-
and WAT-Selective Genes
Next we determined genome-wide Lsd1 chromatin occupancy
in brown adipocytes by chromatin immunoprecipitation using
Lsd1 antibody followed by massive parallel sequencing (ChIP-
seq). The antibody was validated previously and specifically rec-
ognizes Lsd1 (Duteil et al., 2014). We found that Lsd1 occupied
the promoter of 75%of the BAT-selective genes (103 genes) and
68% of the WAT-selective genes (158 genes) differentially regu-
lated in Lsd1cKO mice (Figure 2G), suggesting a dual mechanism
by which Lsd1 represses the expression of WAT-selective genes
while activating that of BAT-selective genes.
Hypergeometric optimization of motif enrichment (HOMER)
motif searches revealed that promoter occupancy of Lsd1 signif-
icantly correlated with the presence of binding sites for the
transcription factors Nrf1 and Rest (Figure 2H). Thus, we hypoth-
esized that Lsd1 might positively regulate BAT-selective genes
in cooperation with Nrf1 while repressing WAT-selective gene
expression in concert with the CoREST complex. ChIP with
Nrf1 antibody followed by qPCR analysis in brown adipocytes
showed that Lsd1 and Nrf1 co-localized at promoters of repre-
sentative BAT-selective genes such as Acadm, Oplah, and
Cox6a1 (Figure 3A). Ucp1 was not part of the analysis because
our genome-wide cistrome analysis by ChIP-seq showed no
Lsd1 occupancy. Importantly, Nrf1 was not present at the pro-
moter of WAT-selective genes, as illustrated by Figure S3A.
Because Lsd1 is known to activate gene expression by erasing
dimethyl groups at lysine 9 of histone 3 (H3K9me2), we hypoth-
esized that inhibition of Lsd1 would modify methylation levels of
H3K9 at BAT-selective genes. ChIP-qPCR analysis for H3K9me2
revealed that levels of H3K9me2 were increased upon Lsd1(i)
treatment at promoters of BAT-selective genes (Figure 3B). In
parallel, levels of H3K4me2 were reduced in Lsd1(i)-treated cells
(Figure S3B), indicating a repressive transcriptional context. To
investigate whether Lsd1 and Nrf1 are present in the same pro-
tein complex, nuclear extracts from brown adipocytes were sub-
jected to size exclusion chromatography. Western blot analysis
showed that Lsd1 and Nrf1 co-fractionate, suggesting the
existence of an Nrf1/Lsd1complex (Figure S3C). Furthermore,
Lsd1 and Nrf1 co-immunoprecipitated, confirming interaction
AC
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B Figure 2. The Demethylase Activity of Lsd1
Is Required to Maintain BAT Properties
(A and B) Macroscopic view (A) and H&E staining
(B) of representative sections of BAT of mice
treated with vehicle or Lsd1(i).
(C and D) Relative mRNA levels of WAT-selective
(C) and BAT-selective (D) genes in BAT of mice
treated with vehicle or Lsd1(i) (mean + SEM, *p <
0.05, **p < 0.01, ***p < 0.001; vehicle, n = 6; Lsd1(i),
n = 7).
(E) Western blot analysis of Lsd1, Ucp1, and Apoe
in BAT of mice treated with vehicle or Lsd1(i).
b-Tubulin was used as a loading control.
(F) Oil red O staining of differentiated primary
brown adipocytes treated with vehicle or Lsd1(i).
(G) Pie chart depicting BAT- and WAT-selective
genes with Lsd1 peaks at promoters in differenti-
ated primary brown adipocytes.
(H) HOMER motif analysis of Lsd1 ChIP-seq data
unraveled Rest and Nrf1 binding sites among the
top-scoring motifs.
Scale bars, 5 mm (A), 100 mm (B), 50 mm (F). See
also Figure S2.between these two endogenously expressed proteins in BAT
(Figure S3D). Accordingly, small interfering RNA (siRNA)-medi-
ated knockdown of Nrf1 (Figure S3E) significantly decreased
transcript levels of BAT-selective genes but did not impair
WAT-selective gene expression (Figure 3C). Together, these
data demonstrate that Lsd1 controls the expression of BAT-
selective genes in cooperation with Nrf1 by targeting H3K9
methylation levels.Rc
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the WAT-selective gene program in BAT.
For this purpose, nuclear protein extracts
from BAT were used for immu-
noprecipitation with three distinct anti-
Lsd1 antibodies directed against various
Lsd1 domains followed by liquid chro-
matography-tandem mass spectrometry
(LC-MS/MS). The intersection of the
three interactomes uncovered 163 pro-
teins commonly interacting with Lsd1
(Figure S3F) and revealed the repressive
CoREST complex as a significantly en-
riched protein group (Table S2). Interac-
tion between Lsd1 and CoREST has
already been well established (Lee et al.,
2005; Metzger et al., 2005; Shi et al.,
2004). Accordingly, co-immunoprecipita-
tion experiments and size exclusion chro-
matography demonstrated that, also in
BAT, endogenous Lsd1 interacts with
members of the CoREST complex (Fig-
ures S3G and S3H). To test whether
the CoREST complex indeed represses
the expression of WAT-selective genes,
we knocked down the complex membersor1 and Rcor3 in brown adipocytes (Figure S3I). Cells treated
th Rcor1 or Rcor3 siRNA upregulated WAT-selective genes
igure 3D) without affecting BAT-selective genes, as exempli-
d by Oplah and Acadl (Figure 3D), and accumulated more
ids than cells treated with control siRNA (Figure S3J). In addi-
n, ChIP-qPCR analyses confirmed the colocalization of Rcor1
d Rcor3 with Lsd1 specifically at promoters of WAT-selective
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(Figure S3K). Because Lsd1 is known to repress gene expression
by erasing dimethylation of lysine 4 of histone 3 (H3K4me2), we
analyzed whether inhibition of Lsd1 is sufficient to alter methyl-
ation levels of H3K4 at WAT-selective genes. ChIP-qPCR anal-
ysis showed that levels of H3K4me2 were increased upon
Lsd1(i) treatment at promoters of WAT-selective genes (Fig-
ure 3F). Concomitantly, levels of H3K9me2 were decreased at
these promoters (Figure S3L), indicating an active transcriptional
context. Together, our data demonstrate that Lsd1 represses
WAT-selective gene expression in cooperation with the CoREST
complex in BAT by reciprocal modulation of H3K4 and H3K9
methylation levels.
Loss of Lsd1 Induces Glycolysis while Repressing
Oxidative Metabolism in BAT
Lsd1cKO mice exhibit a profound morphological whitening of
BAT associated with large lipid accumulation. To identify further
changes in global gene expression in Lsd1cKO mice that might
account for the observed whitening of Lsd1-depleted brown
fat, we performed a pathway enrichment analysis of the tran-
scriptome data. The analysis (Figure 4A) uncovered pathways
regulating energy production and fatty acid catabolism such
as the tricarboxylic acid (TCA) cycle, electron transport chain
(ETC), and b-oxidation. The expression of genes representing
these pathways was downregulated (Figure 4B; Figure S4A),
suggesting that oxidative metabolism is lowered in BAT of
Lsd1cKO mice, confirming our data in WAT (Duteil et al., 2014).
Interestingly, the second most enriched pathway was ‘‘glycol-
ysis and gluconeogenesis,’’ which we did not observe in WAT.
In line with these findings, we observed increased expression
of glucose transporters and the majority of glycolytic enzymes
catalyzing glucose-to-pyruvate conversion in Lsd1cKOmice (Fig-
ure 4B; Figure S4B). We thus hypothesized that Lsd1 deficiency
in BAT not only leads to reduction of oxidative functions but
also increases glycolytic capacities. To evaluate bioenergetic
changes upon inhibition of Lsd1, we employed a Seahorse XF
analyzer (Agilent Technologies) to measure the extracellular
acidification rate (ECAR) as an index of glycolytic activity (using
a glycolysis stress kit) and the oxygen consumption rate (OCR)
as an index of respiratory capacity (using the Cell Mito stress
test kit) in brown adipocytes treated with Lsd1(i) or vehicle. The
rate of glycolysis following glucose administration was higher
upon Lsd1(i) treatment compared with vehicle (Figure 4C;
Figure S4C). After addition of oligomycin, an inhibitor of mito-
chondrial ATP synthesis, the maximum glycolytic capacity of
Lsd1(i)-treated cells remained higher than in control cells,
demonstrating that not only the rate of glycolysis but also theFigure 3. Lsd1 Regulates the Brown Fat Program through a Dual Mech
(A and B) ChIP analysis to detect promoter occupancy performed with anti-Lsd1
brown adipocytes (A) and anti-H3K9me2 antibody or mouse IgG (mIgG) in brown
quantified by qPCR analysis with primers flanking Lsd1-binding sites in the indic
(C and D) Relative mRNA levels of the indicated BAT- orWAT-selective genes in b
directed against Lsd1 (siRNA Lsd1) or Nrf1 (siRNA Nrf1) (C) and with siRNA Ctrl
(E and F) ChIP analysis to detect promoter occupancy performed with anti-Lsd1, a
Lsd1 and anti-H3K4me2 antibody or rbIgG in brown adipocytes treated with Lsd
with primers flanking Lsd1-binding sites in the indicated genes
Data are mean + SEM. (A), (C), (D), and (E): one-way ANOVA. (B) and (F): two-way A
in triplicate. See also Figure S3 and Tables S2, S4, and S5.glycolytic reserve capacity were enhanced in Lsd1-inactivated
cells (Figure 4C; Figure S4C). In parallel, the OCR was
lower in Lsd(i)-treated cells compared with vehicle (Figures
S4D and S4E), and, subsequently, the OCR/ECAR ratio was
decreased, demonstrating that Lsd1 inhibition shifted mitochon-
drial metabolism toward the glycolytic pathway in brown adipo-
cytes (Figure 4D). Furthermore, oxygen consumption resulting
from mitochondrial respiration measured in BAT of Lsd1cKO
mice was reduced compared with control mice, confirming
lower oxidative phosphorylation (Figure S4F). Taken together,
our data show that glycolytic activity is enhanced in the absence
of Lsd1, whereas oxidative phosphorylation is reduced.
In addition, glucose uptake and activity of key glycolytic
enzymes such as hexokinase (Hk), phosphofructokinase (Pfk),
enolase (Eno), and lactate dehydrogenase (Ldh) were higher in
BAT of Lsd1cKO mice compared with control mice (Figure 4E),
promoting increased glycolytic capacity.
Of note, the expression levels of genes involved in pyruvate
metabolism, including the rate-limiting mitochondrial pyruvate
transporters (Mpc1 and Mpc2) and enzymes catalyzing the con-
version from pyruvate to acetyl-coenzyme A (CoA) (e.g., Dlat and
Pdhx), were decreased in Lsd1cKO mice (Figure 4B; Figure S4G).
Our genome-wide analysis also revealed that expression of glu-
tamic-oxaloacetic transaminase 1 (Got1) and 2 (Got2) as well as
Slc25a12 and phosphoenolpyruvate carboxykinase 2 (Pck2)
was upregulated in Lsd1cKO mice compared with control (Fig-
ure 4B; Figure S4G). Got1 and 2 are responsible for conversion
of downstream pyruvate intermediate oxaloacetate into aspar-
tate and phosphoenolpyruvate, respectively (Birsoy et al.,
2015). In particular, Got1 was shown to be essential for aspartate
regeneration to restore ETC dysfunction (Birsoy et al., 2015).
ETC dysfunction is associated with a drop in nicotinamide
adenine dinucleotide (NAD+)/NADH ratio because NAD+ cannot
be oxidized by complex I. However, despite decreased oxida-
tive phosphorylation (OXPHOS), the NAD+/NADH ratio was
increased in BAT of Lsd1cKO mice (Figure S4H). This might be,
at least in part, mediated by higher Got1 activity (Figure 4E).
An Increased NAD+/NADH ratio is also in favor of increased
glycolysis (Zhang et al., 2007).
Similarly, expression profiling of metabolic genes in Lsd1cKI
mice and mice treated with Lsd1(i) revealed that Lsd1 demethy-
lase activity strongly contributes to maintaining proper energy
metabolism in BAT (Figures S4B, S4G, and S4I). Taken together,
these data show that glycolysis is enhanced in Lsd1-inactivated
BAT, whereas oxidative metabolism is lowered.
The analysis of genome-wide Lsd1 chromatin occupancy in
BAT by ChIP-seq revealed that glucose transporters and genesanism
and anti-Nrf1 antibodies or rabbit immunoglobulin G (IgG) (rbIgG) in wild-type
adipocytes treated with Lsd1(i) or vehicle (B). The precipitated chromatin was
ated genes.
rown adipocytes transfected with unrelated control siRNA (siRNA Ctrl) or siRNA
or siRNA directed against Rcor1 (siRNA Rcor1) or Rcor3 (siRNA Rcor3) (D).
nti-Rcor1, and anti-Rcor3 antibodies or rbIgG in brown adipocytes (E) and anti-
1(i) or vehicle (F). The precipitated chromatin was quantified by qPCR analysis
NOVA; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 3; qPCRswere run
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involved in glycolysis are direct targets of Lsd1 (Figure S4J).
ChIP-qPCR of brown adipocytes showed promoter occupancy
of representative genes by Rcor1, Rcor3, and Lsd1 (Figure 4F).
In parallel, the levels of H3K4me2 were enriched, whereas the
levels of H3K9me2 were lowered upon Lsd1(i) treatment (Fig-
ure 4G; Figures S4K and S4L). These results demonstrate that
Lsd1 is directly repressing glycolytic genes to ensure physiolog-
ical metabolic processes in brown adipocytes.
Lsd1 Regulates Lipid Accumulation in BAT
To further investigate our phenotype, we performed metabolo-
mic and lipidomic analyses of BAT of 10-week-old control and
Lsd1cKO mice. These analyses revealed an accumulation of
intermediates of glycolysis, including glyceraldehyde-3-phos-
phate and glycerol, in BAT of Lsd1cKO mice (Figure 5A) accom-
panied by augmentation of long-chain diacyl- and triacylglycer-
ides (DAGs and TAGs, respectively) (Figure 5B). In accordance
with an increase in long-chain fatty acids, the transcript levels
of fatty acid elongases (Elovl1, Elovl4, and Elovl7) and fatty
acid desaturases (Fads1 and Fads2) were upregulated in the
absence of Lsd1 (Figures 4B and 5C) or Lsd1 demethylase activ-
ity (Figures S5A and S5B). The analysis of genome-wide Lsd1
chromatin occupancy in BAT by ChIP-seq revealed that genes
encoding enzymes involved in fatty acid elongation are direct
targets of Lsd1 (Figures S5C–S5F).
DAG and TAG are glycerol esters derived from dihydroxyace-
tone phosphate (DHAP) and fatty acids. Allocation of fatty acids
necessary for glyceride synthesis might be due to decreased
lipolysis, increased de novo lipogenesis, or increased fatty acid
uptake in BAT of Lsd1cKO mice. Increased fatty acid synthase
(Fasn) activity (Figure 5D) and low acetyl-CoA carboxylase phos-
phorylation (Figure S5G) are in favor of enhanced de novo lipo-
genesis in Lsd1cKO mice. To assess lipolysis efficiency, we
measured lipase activity. The activity of lipases present in brown
adipocytes was reduced by 50% in Lsd1cKO mice, suggesting
that hydrolysis of lipids into fatty acids is severely impaired (Fig-
ure 5E). In addition, the activity of lipoprotein lipase (Lpl), which
hydrolyzes triglycerides in lipoproteins such as those found in
chylomicrons and very low-density lipoprotein (VLDL) to facili-
tate fatty acid uptake from the bloodstream, was increased
upon loss of Lsd1 (Figure 5F). Finally, to test whether fatty acid
oxidation was altered, we measured mitochondrial respiration
in the presence of palmitoyl-L-carnitine as substrate in sapo-
nine-permeabilized BAT. The data revealed that Lsd1-deficient
BAT failed to properly use fatty acids (Figure 5G). Increased fattyFigure 4. Lsd1 Represses Glycolysis in BAT
(A) Enriched pathways obtained from gene ontology (GO) term analysis for gene
(B) Heatmaps depicting mean centered normalized mRNA expression of selecte
processing, and gluconeogenesis in BAT of Ctrl and Lsd1cKO mice at 10 weeks
(C andD) Representative ECAR (C) and OCR divided by ECAR (D) for Lsd1(i)- or ve
analyzer (mean + SEM, ***p < 0.001, n = 6).
(E) Determination of glucose uptake, Hk, Pfk, Eno, Ldh, and Got activities in BAT of
n = 5).
(F andG) ChIP analysis to detect promoter occupancy performed with anti-Lsd1, a
Lsd1 and anti-H3K4me2 antibody or rbIgG in brown adipocytes (G) treated with v
with primers flanking Lsd1-binding sites in the indicated genes (mean + SEM). (F):
0.001, ****p < 0.0001; n = 3; qPCRs were run in triplicate).
See also Figure S4.acid synthesis and lower lipolysis are in agreement with the
observation of an increased NAD+/NADH ratio (Figure S4H).
Altogether, these findings show that Lsd1 regulates lipid accu-
mulation in BAT.
In summary, our data show that Lsd1 positively regulates the
expression of oxidative metabolism-related genes with concom-
itant repression of the gene program responsible for glycolysis
and fatty acid biosynthesis. Accordingly, loss of Lsd1 in brown
adipose tissue drives a shift from oxidative to glycolytic meta-
bolism accompanied by aberrant triglyceride accumulation.
Absence of Lsd1 Improves Glucose Uptake Despite
Increasing Body Weight
Finally, we examined the consequences of Lsd1 loss in BAT with
aging. Lsd1cKO male mice gained significantly more weight
(40%) than their control littermates between 10 and 30 weeks
of age (Figure 6A). No weight differences were observed in fe-
males (Figure S6A). The weight gain of Lsd1cKO mice was not
due to increased food intake or decreased mobility (Figures
S6B–S6D). Body composition analysis assessed with a whole-
body magnetic resonance analyzer (EchoMRI) revealed that
30-week-old Lsd1cKOmice accumulatedmore fat than their con-
trol littermates, resulting in a lower lean/fat mass ratio compared
with control mice (Figure 6B). These data were corroborated by a
dramatically increased BAT mass in 30-week-old Lsd1cKO mice
aswell as in Lsd1cKI mice (Figures S6E and S6F), associated with
45% augmentation in fatty acid content of BAT (Figure 6C). In
accordance, histological analyses revealed a robust phenotypic
conversion of BAT in Lsd1cKO and Lsd1cKI mice to a WAT-
like appearance (Figure S6G). In addition, we noticed robustly
reduced Ucp1 protein levels, as shown by immunocytochem-
istry (Figure S6G). Observed morphological changes in BAT
are accompanied by increased levels of intermediates of glycol-
ysis, glycerol, DAG, and TAG (Figures S6H and S6I).
In 30-week-old Lsd1cKO mice, we observed lower energy
expenditure, determined by decreasedwhole-body oxygen con-
sumption (VO2) (Figure 6D; Figures S6J and S6K) and CO2
production (VCO2) (Figure 6E; Figures S6L and S6M), resulting
in an increased respiratory quotient (RQ, VCO2/VO2 ratio) (Fig-
ure 6F). This confirmed a shift in fuel consumption from fatty
acids to carbohydrates. In addition, calorimetric parameters
deduced from these analyses indicated that energy expenditure
was decreased in Lsd1cKO mice (Figure 6G; Figures S6N and
S6O). This was confirmed by body temperature measurements
(Figure 6H).s differentially expressed in BAT of Lsd1cKO and control mice.
d genes involved in the TCA cycle, fatty acid elongation, glycolysis, pyruvate
of age (Ctrl, n = 4; Lsd1cKO, n = 4).
hicle-treated brown adipocytes determinedwith the Seahorse extracellular flux
Ctrl and Lsd1cKOmice at 10weeks of age (mean + SEM, *p < 0.05, ***p < 0.001,
nti-Rcor1, and anti-Rcor3 antibodies or rbIgG in brown adipocytes (F) and anti-
ehicle or Lsd1(i). The precipitated chromatin was quantified by qPCR analysis
one-way ANOVA. (G): two-way ANOVA. ns: p > 0.05, *p < 0.05, **p < 0.01, ***p <
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Figure 5. Lsd1 Limits Fat Accumulation in BAT
(A) Metabolomic analysis of BAT of control and Lsd1cKO mice.
(B) Lipidomic analysis of BAT from 10-week-old control and Lsd1cKO mice.
(C) Relative mRNA levels of the indicated enzymes involved in fatty acid elongation in BAT of control and Lsd1cKOmice (mean + SEM; **p < 0.01, ***p < 0.001; Ctrl,
n = 9; Lsd1cKO, n = 7).
(D–F) Determination of fatty acid synthase (Fasn), lipase, and Lpl activities in BAT of Ctrl and Lsd1cKO mice at 10 weeks of age (mean + SEM, **p < 0.01,
***p < 0.001, n = 6).
(G) Mitochondrial respiration of BAT extracts from Ctrl and Lsd1cKO mice assessed with a high-resolution respiratory Oxygraph-2K system using palmitoyl-L-
carnitine as substrate (mean + SEM, ***p < 0.001, n = 6).
See also Figure S5 and Tables S4 and S5.Next we analyzedmice for glucose tolerance and insulin sensi-
tivity. We observed that circulating glucose levels in 10-week-old
Lsd1cKOmice were lower compared with control littermates (Fig-
ure 6I). Nevertheless, we did not notice any difference in glucose
tolerance of Lsd1cKO mice relative to control mice at this age
(Figure 6J). Importantly, with aging, control mice developed pro-
gressive glucose intolerance, contrary to Lsd1cKO mice, which1016 Cell Reports 17, 1008–1021, October 18, 2016conserved efficient glucose uptake (Figure 6J). Age-developed
glucose intolerance is generally associated with loss of insulin
sensitivity and contributes to type 2 diabetes. To unravel whether
Lsd1cKO mice are resistant to age-induced type 2 diabetes, we
performed an intraperitoneal insulin sensitivity test (IPIST) and
determined serum insulin levels. Despite dramatic alterations in
glucose metabolism, we did not observe any difference in insulin
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Figure 6. Lsd1cKO Mice Have Higher Glucose Uptake Despite Increased Body Weight
(A) Body weight of control and Lsd1cKO mice at the indicated age (mean + SEM; two-way ANOVA with repeated measures; factor interaction, pgenotype/time <
0.0001; *p < 0.05, ***p < 0.001; n = 7).
(B and C) Body fat and lean content(B) and fatty acid content (C) of 30-week-old control and Lsd1cKO mice. (B) and (C): mean + SEM, *p < 0.05, ***p < 0.001,
****p < 0.0001. (B): two-way ANOVA, n = 7. (C): n = 5.
(D–G) VO2 (D), VCO2 (E), RQ (F), and energy expenditure (G) of 30-week-old control and Lsd1
cKO mice (mean + SEM; *p < 0.05, **p < 0.01; Ctrl, n = 8; Lsd1cKO,
n = 7). VO2, VCO2, and energy expenditure are normalized to the lean mass.
(H) Body temperature of 30-week-old control and Lsd1cKO mice (mean + SEM; **p < 0.01; Ctrl, n = 8; Lsd1cKO, n = 7).
(I) Serum glucose levels of fed Ctrl and Lsd1cKO mice at the indicated ages (mean + SEM; *p < 0.05; Ctrl, n = 8; Lsd1cKO, n = 7).
(J) Intraperitoneal glucose tolerance test (IPGTT) for 10-week-old or 30-week-old control and Lsd1cKO mice starved for 6 hr prior to analysis (mean + SEM; two-
way ANOVA; Ctrl 10-week-old versus Lsd1cKO 10-week-old, ns p > 0.05; Ctrl 10-week-old versus Ctrl 30-week-old, **p < 0.01, ****p < 0.0001; Lsd1cKO 10-week-
old versus Lsd1cKO 30-week-old, ##p < 0.01, ####p < 0.0001; Ctrl 30-week-old versus Lsd1cKO 30-week-old, ns p > 0.05, p^ < 0.05, ^^ p^ < 0.001, ^^^^p < 0.0001;
Ctrl, n = 8; Lsd1cKO, n = 7).
See also Figure S6.
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Figure 7. Lsd1 Governs the Gene Expression Program and Meta-
bolic Functions of Brown Adipose Tissue
Lsd1 controls the properties of BAT via a dual mechanism, resulting in inhi-
bition of WAT-selective and promotion of BAT-selective gene expression. This
opposing function of Lsd1 is orchestrated via interaction with (A) the activating
transcription factor Nrf1 (H3K4me2 marks are depicted in green) and (B) an
Lsd1-containing repressive CoREST complex (H3K9me2 marks are depicted
in red).sensitivity (Figure S6P) or in total insulin levels (Figure S6Q),
showing that only glucose but not insulin metabolism is altered
in Lsd1cKO mice. In summary, these data show that Lsd1 is
required in BAT to maintain a proper energy balance with aging.
DISCUSSION
White and brown adipocytes have distinct transcriptional pro-
grams that facilitate long-term lipid storage or thermogenesis,
respectively. Understanding these programs is of the highest in-
terest for developing new strategies to counteract obesity. The
epigenetic determinants that regulate white versus brown fat-se-
lective gene expression have not yet been completely eluci-
dated. In this study, we show that the histone demethylase
Lsd1 plays a key role in the maintenance of brown fat metabolic
properties. Lsd1 accomplishes this mission via a dual mecha-
nism by inhibiting the expression of WAT-selective genes and
simultaneously promoting the expression of BAT-selective
genes. These opposing functions of Lsd1 are orchestrated by
the assembly in different protein complexes: a repressive
CoREST complex to inhibit the expression of WAT-selective
genes and an Nrf1-containing complex to promote the expres-
sion of BAT-selective genes (Figure 7). Our data point out the
importance of Lsd1 demethylase activity in controlling BAT
metabolism in vivo. Indeed, our engineered mouse model,
Lsd1cKI mice, as well as wild-type mice treated with an Lsd1-
specific inhibitor, basically recapitulate the phenotype observed
in Lsd1cKO mice. Alterations in BAT morphology and transcrip-
tome in Lsd1cKI and Lsd(i)-treatedmice resemble that of Lsd1cKO
mice and suggest that catalytically active Lsd1 significantly con-
tributes to themaintenance of the BAT gene expression program1018 Cell Reports 17, 1008–1021, October 18, 2016and function. However, additional scaffolding functions of Lsd1,
which might be independent of the enzymatic activity (i.e., the
recruitment of proteins and/or the assembly in different protein
complexes) might be impaired upon loss of Lsd1 in Lsd1cKO
mice. In contrast, in knockin mice, the enzymatically inactive
Lsd1 mutant protein might be able to perform, at least in part,
these functions, which might explain a less severe phenotype.
Lsd1 exerts its function in brown adipocytes by engaging
in different protein complexes. Coordinated action of Lsd1
with members of the CoREST complex, in particular Rcor1 and
Rcor3, represses the expression of WAT-selective genes.
Although Lsd1 has been shown to interact with CoREST in
various tissues (Lee et al., 2005; Metzger et al., 2005; Shi et al.,
2004; Yang et al., 2011), the physiological function of CoREST
in vivo remains unclear. Here we demonstrate for the time that
the CoREST complex plays a critical role in the repression of
the WAT-selective genes in BAT, thereby strongly contributing
to the maintenance of brown fat characteristics. In BAT, Lsd1
specifically associates with Rcor1 and Rcor3 but not Rcor2.
Similar to Lsd1, Rcor1 is ubiquitously expressed in somatic cells,
whereas the expression of Rcor2 and Rcor3 seems to be more
restricted (Yang et al., 2011). This suggests that the Lsd1 core-
pressor complex might assemble with different Rcor family
members to carry out specific functions in different cell types.
Furthermore, Lsd1 interacts with Nrf1 to activate the expres-
sion of BAT-selective genes. We have shown previously that,
in WAT, Lsd1 acts together with Nrf1 to positively regulate
OXPHOS and thermogenesis (Duteil et al., 2014). Elevated
Lsd1 levels favor beigening of WAT by increasing oxidative
metabolism, uncoupling, thermogenesis, and the number and
size of mitochondria. Our data provide evidence that the
absence of Lsd1 in BAT causes dramatic mitochondrial dysfunc-
tion associated with decreased transcript levels of OXPHOS-
related genes. It is interesting that Lsd1 in cooperation with
Nrf1 shares comparable functions in beige and brown adipo-
cytes. Whether the mechanism of regulation of oxidative meta-
bolism is conserved in all metabolically active tissues remains
unclear. To clarify this hypothesis, it would be necessary to
analyze the metabolism of skeletal muscle and liver in Lsd1
knockout mice.
Our analyses uncovered that Lsd1 is necessary to regulate
metabolism, particularly fatty acid oxidation, de novo lipogen-
esis, and lipolysis, leading to increased DAG and TAG accumu-
lation andwhitening of Lsd1cKO BAT. In addition, Lsd1 depletion/
inhibition leads to elevated glucose uptake and increased glyco-
lytic capacities in mice. This may contribute to DAG and TAG
accumulation because the glycerol backbone for triglyceride
synthesis can be derived from the glycolytic intermediate dihy-
droxyacetone phosphate. Furthermore, pyruvate is converted
into citrate in the TCA cycle and utilized to provide acetyl-CoA
to initiate de novo lipogenesis. However, further experiments
would be necessary to provide a direct link between these
processes. Nevertheless, the role of Lsd1 in lipid metabolism
has been confirmed in this study because Lsd1cKO mice show
increased activity of fatty acid synthase and decreased activity
of lipases. Altogether, alterations in glycolysis and fatty acid
oxidation might contribute to aberrant production of DAG and
TAG, which leads to increased fat accumulation.
Transcriptional and metabolic changes induced by Lsd1
ablation have secondary effects on body weight gain and
glucose tolerance with aging. Indeed, Lsd1cKO mice gained
significantly more weight than their control littermates. These
findings are of interest, considering that many mouse models
possessing defects in adipose tissue function and metabolism,
such as loss of mitochondrial uncoupling (Liu et al., 2003) and
fatty acid or ceramide metabolism (Ellis et al., 2010; Lee
et al., 2016; Schoiswohl et al., 2015; Turpin et al., 2014), do
not develop obesity. A hypothesis might be that Lsd1-deficient
brown adipocytes secrete signaling molecules that exert a po-
tential inhibitory function on energy expenditure in other meta-
bolic organs such as white adipose tissue, liver, or muscle.
Consequently, we carefully inspected our transcriptome anal-
ysis for differential expression of endocrine molecules, cyto-
kines, or other signaling molecules. This analysis failed to
identify any known candidates that might explain the phenotype
in our mice. This, however, does not exclude the possibility that
Lsd1 regulates the expression of yet undescribed endocrine
molecules in brown adipocytes. Future studies will be required
to elucidate this issue.
Previous studies showed that the ablation of the brown
fat-determining transcriptional regulator Prdm16 is required to
suppress the expression of WAT-selective genes in BAT (Harms
et al., 2014) similar to Lsd1. However, the expression of the most
typical BAT-selective genes was only slightly reduced upon
Prdm16 ablation, which could explain why Prdm16 knockout
mice are not prone to obesity (Harms et al., 2014). In line with
this publication, Zeng et al. (2016) showed that Lsd1 associates
with Prdm16 to repress expression of WAT-selective genes. Of
note, our ChIP-seq data identified Prdm16 as a direct Lsd1
target, and Prdm16 expression was reduced in Lsd1-deleted
BAT. However, immunoprecipitation, size exclusion chromatog-
raphy, and mass spectrometry analyses did not provide any ev-
idence for association of Lsd1 and Prdm16 in BAT, suggesting
that Lsd1 acts upstream of Prdm16. Zeng et al. (2016) also claim
that Lsd1 represses the expression of hydroxysteroid 11-
b-dehydrogenase isozyme 1 (Hsd11b1) independently from
Prdm16. Even though Hsd11b1 is 1.5-fold upregulated in our
Lsd1cKO mice, our cistrome analysis did not provide any evi-
dence for binding of Lsd1 to the Hsd11b1 promoter. Even though
the phenotypes of our Lsd1cKO mice and the mice engineered by
Zeng et al. (2016) are close, the differences observed in the
follow-up cistrome and transcriptome analyses and the interpre-
tation of the molecular mechanism could be explained by the
fact that they did not use a brown fat-specific Cre deleter strain.
Recently, Sambeat et al. (2016) proposed that Zfp516 associ-
ates with Lsd1 to promote Ucp1 promoter occupancy and gene
expression. In clear contrast, our mass spectrometry analysis
does not confirm interaction of endogenously expressed Lsd1
and Zfp516 in brown adipocytes. In addition, our ChIP-seq
showed that the Ucp1 promoter is not occupied by Lsd1 in
brown adipocytes.
Our findings indicate that the use of Lsd1 inhibitors would
lead to a shift from oxidative to glycolytic metabolism in
BAT, resulting in weight gain but improved glucose toler-
ance. These findings need to be considered because Lsd1 in-
hibitors entered clinical trials, for example in the treatment ofmixed-lineage leukemia (Feng et al., 2016). In conclusion,
our data identify Lsd1 as a key epigenetic regulator of BAT
metabolism.
EXPERIMENTAL PROCEDURES
Mouse Studies
All mice were housed in the pathogen-free barrier facility of the University
Medical Center Freiburg in accordance with institutional guidelines approved
by the regional board. Mice were maintained in a temperature- and humidity-
controlled animal facility with a 12-hr light/dark cycle, free access to water,
and a standard rodent chow (Kliba, breeding, 3807). Male mice were
analyzed at 10 or 30 weeks of age. Animals were killed by cervical dislo-
cation, and tissues were immediately collected, weighed, frozen in liquid
nitrogen, or processed for further analyses. In vivo experiments, including
food consumption, serum analysis, glucose tolerance tests, temperature
measurements, and energy expenditure, were described previously (Duteil
et al., 2014). The Lsd1 inhibitor QC6688 was administrated per os at
5 mg/kg in 0.5% methylcellulose (Sigma; product M0512-110G; viscosity,
4,000 centipoise [cP]).
Cellular Metabolism
Cellular metabolic rates were measured using an XF24 analyzer (Seahorse
Bioscience). Immediately before themeasurement, cells werewashedwith un-
buffered DMEM as described previously (Wu et al., 2007). Plates were placed
into the XF24 instrument for measurement of OCR and ECAR with the XFp
glycolysis stress kit (103017-100, Seahorse) for ECAR measurements
(glucose, 10 mM; oligomycin, 1 mM; and 2 deoxiglucose (2-DG), 50 mM) or
the Cell Mito stress kit (103010-100, Seahorse) for OCR measurements (oligo-
mycin, 1 mM; carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP),
0.5 mM; and rotenone/antimycin A, 0.25 mM).
Lipid Quantification
Total lipids were extracted from 50 mg of BAT using a lipid extraction kit (STA-
612, Cell Biolabs) and quantified using a lipid quantification kit (STA-613, Cell
Biolabs) according to the manufacturer’s recommendations.
Quantification of Mitochondrial and Nuclear DNA
BAT was digested overnight with Proteinase K, and DNA was extracted with
phenol-chloroform. Mitochondria and nuclear DNA were amplified by qPCR
using Cox2 and Fasn primers (Table S4), respectively.
Metabolomic and Lipidomic Analyses
Tissue samples were grinded with a RetschMM440 instrument and further ex-
tracted as described in Giavalisco et al. (2009). LC-MS measurements were
performed using a Waters ACQUITY ultra performance liquid chromatography
(UPLC) system coupled to a Thermo Fisher Scientific QExactive mass spec-
trometer. Details of the analysis are presented in the Supplemental Experi-
mental Procedures.
Data Analysis
Data are represented as mean + SEM. Significance was calculated by
(1) two-tailed Student’s t test for Figures 1G and 1H, 2C and 2D, 4D and
4E, 5C–5G, and 6C–6I and Figures S1A, S1D, S2A, S2C, S2D, S4B,
S4C, S4E–S4I, S5A, S5B, S6B–S6E, S6J, S6L, S6N, and S6Q;
(2) one-way ANOVA for Figures 3A and 3C–3E and 4F and Figures S3A,
S3E, S3K, and S5D;
(3) two-way ANOVA for Figures 3B and 3F, 4G, and 6A, 6B, and 6J and
Figures S3B, S3L, S4K, S4L, S5E, S5F, S6A, and S6P;
(4) Wilcoxon rank-sum test for Figures 5A and 5B and Figures S6H and
S6I; and
(5) analysis of covariance (ANCOVA) for Figures S6K, S6M, and S6O.
Heatmaps were generated by centering and normalizing expression values
with Cluster 3.0 and importing them to MeV viewer.Cell Reports 17, 1008–1021, October 18, 2016 1019
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